These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35034685)

  • 1. Chronic testicular pain cured by low-dose pramipexole: is there an association with restless legs syndrome?
    Silva LMT; Lenz MDCS; Martinez D
    J Clin Sleep Med; 2022 May; 18(5):1467-1469. PubMed ID: 35034685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restless legs syndrome mimicking S1 radiculopathy.
    Zambelis T; Wolgamuth BR; Papoutsi SN; Economou NT
    Psychiatriki; 2016; 27(3):222-226. PubMed ID: 27837576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restless legs syndrome: differential diagnosis and management with pramipexole.
    Brindani F; Vitetta F; Gemignani F
    Clin Interv Aging; 2009; 4():305-13. PubMed ID: 19750232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferential D2 or preferential D3 dopamine agonists in restless legs syndrome.
    Manconi M; Ferri R; Zucconi M; Clemens S; Giarolli L; Bottasini V; Ferini-Strambi L
    Neurology; 2011 Jul; 77(2):110-7. PubMed ID: 21715702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First night efficacy of pramipexole in restless legs syndrome and periodic leg movements.
    Manconi M; Ferri R; Zucconi M; Oldani A; Fantini ML; Castronovo V; Ferini-Strambi L
    Sleep Med; 2007 Aug; 8(5):491-7. PubMed ID: 17512780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restless legs syndrome in patients with type 2 diabetes: effectiveness of pramipexole therapy.
    Harashima S; Nishimura A; Osugi T; Wang Y; Liu Y; Takayama H; Inagaki N
    BMJ Support Palliat Care; 2016 Mar; 6(1):89-93. PubMed ID: 25216659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High national rates of high-dose dopamine agonist prescribing for restless legs syndrome.
    Winkelman JW
    Sleep; 2022 Feb; 45(2):. PubMed ID: 34417810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose pramipexole in the management of restless legs syndrome. An open label trial.
    Stiasny-Kolster K; Oertel WH
    Neuropsychobiology; 2004; 50(1):65-70. PubMed ID: 15179023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron for the treatment of restless legs syndrome.
    Trotti LM; Becker LA
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD007834. PubMed ID: 30609006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dose-ranging study of pramipexole for the symptomatic treatment of restless legs syndrome: polysomnographic evaluation of periodic leg movements and sleep disturbance.
    Jama L; Hirvonen K; Partinen M; Alakuijala A; Hublin C; Tamminen I; Koester J; Reess J
    Sleep Med; 2009 Jun; 10(6):630-6. PubMed ID: 19171500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensory symptoms in restless legs syndrome: the enigma of pain.
    Winkelman JW; Gagnon A; Clair AG
    Sleep Med; 2013 Oct; 14(10):934-42. PubMed ID: 23948222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pramipexole in the treatment of restless legs syndrome: a follow-up study.
    Montplaisir J; Denesle R; Petit D
    Eur J Neurol; 2000 May; 7 Suppl 1():27-31. PubMed ID: 11054156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of restless legs syndrome during opioid discontinuation.
    McCarter SJ; Labott JR; Mazumder MK; Gebhard J; Cunningham JL; Loukianova LL; Gilliam WP; Lipford MC
    J Clin Sleep Med; 2023 Apr; 19(4):741-748. PubMed ID: 36692170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sternberg working memory performance following treatment with pramipexole in patients with moderate-to-severe restless legs syndrome.
    Jung KY; Kim SM; Song JY; Lee BU; Lee C; Lee SK; Koo YS; Cho YW; Choi JW; Kim KH
    Sleep Med; 2015 Jun; 16(6):703-8. PubMed ID: 25934537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmentation in patients with restless legs syndrome receiving pramipexole therapy: a retrospective study in a single center from China.
    Wang T; Ying M; Zhao R; Zhu D; Zhang L
    Sleep Breath; 2022 Mar; 26(1):373-380. PubMed ID: 33864178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pramipexole for the treatment of restless legs syndrome.
    Kushida CA
    Expert Opin Pharmacother; 2006 Mar; 7(4):441-51. PubMed ID: 16503816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restless legs syndrome in DNAJC12 deficiency.
    Porta F; Neirotti A; Spada M
    Neurol Sci; 2023 Jun; 44(6):2167-2172. PubMed ID: 36897462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The acute effect of a low dosage of pramipexole on severe idiopathic restless legs syndrome: an open-label trial.
    Merlino G; Dolso P; Canesin R; Cancelli I; Valente M; Gigli GL
    Neuropsychobiology; 2006; 54(3):195-200. PubMed ID: 17314491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restless legs syndrome improved by pramipexole: a double-blind randomized trial.
    Montplaisir J; Nicolas A; Denesle R; Gomez-Mancilla B
    Neurology; 1999 Mar; 52(5):938-43. PubMed ID: 10102409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restless leg syndrome in spinal cord injury: case report.
    McNamara S; Hon B; Kirshblum S
    Spinal Cord Ser Cases; 2023 May; 9(1):19. PubMed ID: 37137889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.